|ACR 2011 Research Update - PDL-1 Molecule and Lupus|
Hear Dr. Anne Stevens from Seattle Children's Hospital speak about the role the PDL-1 molecules play in people with lupus.
Keywords: lupus research; rheumatology; marker
|ACR 2011 Research Update - Cognitive Impairment and White Matter Changes in Pediatric Lupus|
Hear Dr. Eyal Muscal from Baylor College of Medicine speak about the ability to detect changes in the brains of children with lupus that may appear normal with the use of conventional brain imaging methods.
Keywords: lupus research; CNS; NPSLE
|ACR 2011 Research Update - Drs. Buyon and Salmon on Pregnancy in Women with Lupus - Lupus Foundation of America|
ACR 2011 Research Update - Drs. Buyon and Salmon on Pregnancy in Women with Lupus
Keywords: lupus research; pregnancy
|ACR 2011 Research Update - LFA's Collective Data Analysis Initiative|
Hear Dr. Kenneth Kalunian from UCSD speak about LFA's Collective Data Analysis Initiative (CDAI), which was launched so we can learn about the impacts that background therapies may have had on lupus clinical trial outcomes and use that knowledge to improve the design of future trials of potential new therapies for lupus.
Keywords: lupus research; treatment; drug development
|ACR 2011 Research Update - Vitamin D and Lupus - Lupus Foundation of America|
Learn more about Dr. Petri's study regarding vitamin D supplementation in people with lupus.
Keywords: Vitamin D; Lupus; Lupus research
|Acr 2011 Research Update - Possible Marker to Predict Organ Involvement in Lupus|
Investigators discovered that high levels of osteopontin, a protein in the blood, may be a predictor of future disease activity and organ damage in both adults and children with lupus. This biomarker could help physicians determine a proper course of therapy much earlier. Listen to the podcast to learn more
Keywords: lupus research; biomarker; organ damage
|ACR 2011 Research Update - Diagnosing Lupus Criteria - Lupus Foundation of America|
Hear JHU's Dr. Michelle Petri speak about the Systemic Lupus International Collaborating Clinic's (SLICC) revision of the American College of Rheumatology (ACR) SLE classification criteria and validation of the new criteria in order to improve clinical relevance, meet more stringent methodology requirements and incorporate new knowledge in SLE immunology.
Keywords: diagnosing lupus; lupus research; new criteria
|The EMBODY Program: A Clinical Study of Epratuzumab - Lupus Foundation of America, Inc. National Office|
Theresa Lawrence Ford, M.D., Medical Director, North Georgia Rheumatology Group Lawrenceville, Georgia discusses the EMBODY Program, a Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical study of the efficacy and safety of the investigational drug epratuzumab for the potential treatment of Systemic Lupus Erythematosus in people with moderate to severe disease.
Keywords: lupus; systemic lupus erythematosus; SLE; embody; epratuzumab; clinical study; lupus treatment; lupus research; LFA; lupus foundation of america; lupus foundation; treatment for lupus